Utilities Registry – Page 4 – Center for Health Decision Science

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 31 - 40 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of COVID-19 health state utilities (Huarcaya-Victoria J et al., Qual Life Res. 2023. doi:10.1007/s11136-022-03208-w)	2020	EQ-5D-5L	Peru	COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics prospective sample of 119 hospitalized patients who survived COVID-19 at 3 and 13 months after discharge
Title Selection of mental health health state utilities (Adu MK et al., Brain Sci. 2023. doi:10.3390/brainsci13020293)	Year(s) of data collection 2020 - 2022	Valuation Method EQ-5D-5L	Country Canada	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 78 participants in the patient-centered randomized controlled pilot trial investigating combining repetitive transcranial magnetic stimulation with internet-delivered cognitive behavior therapy for the treatment of resistant depression
Title Selection of autoimmune disease health state utilities (Armuzzi A et al., BMC Gastroenterol. 2023. doi:10.1186/s12876-023-02640-7)	Year(s) of data collection 2020 - 2021	Valuation Method EQ-5D-5L	Country France, Germany, Italy, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America	Condition Ulcerative colitis
DOI 10.7910/DVN/XTLOGB Author(s) Registry, Utilities Description Health state utilities for autoimmune disease conditions Sample Characteristics a point-in-time survey of 164 matched patients treated with tofacitinib
Title Selection of orthopedic and musculoskeletal health state utilities (Kontodimopoulos N et al., J Clin Med. 2022. doi:10.3390/jcm11144097)	Year(s) of data collection 2020	Valuation Method EQ-5D-3L, EQ-5D-5L, SF-6D	Country Greece	Condition Ankylosing spondylities, Musculoskeletal disorders, Osteopenia/Osteporosis, Psoriaticc arthritis, Rheumatiod arthritis
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics A cross-sectional sample of 315 (total) consecutive patients clinically diagnosed with RA, PsA, AS, or OsP/OP
Title Selection of orthopedic and musculoskeletal health state utilities (Hustedt JW et al., J Hand Surg Am. 2023. doi:10.1016/j.jhsa.2022.11.021)	Year(s) of data collection 2020 - 2021	Valuation Method EQ-5D	Country United States of America	Condition Thumb carpometacarpal arthritis
DOI 10.7910/DVN/VR4XYO Author(s) Registry, Utilities Description Health state utilities for orthopedic and musculoskeletal conditions Sample Characteristics A prospective clinical trial of 48 participants comparing denervation with suspension arthroplasty for treatment of carpometacarpal arthritis of the thumb
Title Selection of COVID-19 health state utilities (Philip KEJ et al. Lancet Respir Med. 2022. doi:10.1016/S2213-2600(22)00125-4)	Year(s) of data collection 2021	Valuation Method SF-6D	Country United Kingdom of Great Britain and Northern Ireland	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 150 people in RCT of breathing and wellbeing programme for people with persistent symptoms following COVID-19
Title Selection of COVID-19 health state utilities (Chakravarty R et al., Indian J Psychol Med. 2023. doi:10.1177/02537176221140557)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L	Country India	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 80 COVID-19 patients treated with single infusion tocilizumab or no treatment
Title Selection of COVID-19 health state utilities (Shah C et al., Lung India. 2023. doi:10.4103/lungindia.lungindia_126_22)	Year(s) of data collection 2021	Valuation Method EQ-5D-3L	Country India	Condition COVID-19
DOI 10.7910/DVN/MJ4J77 Author(s) Registry, Utilities Description Health state utilities for states related to COVID-19 Sample Characteristics 388 patients with confirmed COVID-19 who had been treated and discharged after hospitalization
Title Selection of oncology health state utilities (Cooper OAE et al., Pharmacoecon Open. 2023. doi:10.1007/s41669-023-00392-4)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Invasive bladder cancer
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics 202 individuals from UK general public
Title Selection of general population health health state utilities (Nikl A et al., Health Qual Life Outcomes. 2023. doi:10.1186/s12955-023-02096-z)	Year(s) of data collection 2021	Valuation Method 15D, EQ-5D-5L	Country Hungary	Condition General population health
DOI 10.7910/DVN/OE5E2K Author(s) Registry, Utilities Description Health state utilities for general population health conditions Sample Characteristics 1887 participants in the online cross-sectional survey

← Previous results Next results →